BioCentury
ARTICLE | Company News

Cel-Sci, Northeastern Ohio Universities College of Medicine deal

October 7, 1996 7:00 AM UTC

The parties agreed to identify and test peptides associated with herpes simplex virus (HSV) using CELI's heteroconjugate technology, which combines T cell binding ligands with disease associated pepti...